3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase NA
2
Phase 4
2
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Thrombosis
1
Thromboembolism
1
Stroke
1
Soft Tissue Neoplasms
1
Sarcoma
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hemorrhage
1
Hematologic Neoplasms
1
Anastomotic Leak
1
Interventions
Rivaroxaban
3
apixaban
2
Heparin, Low-Molecular-Weight
2
Fondaparinux
2
Enoxaparin
2
Dalteparin
2
enoxaparin sodium
1
edoxaban
1
Warfarin
1
Tinzaparin
1
Nadroparin
1
Long-Term Synaptic Depression
1
Hematologic Tests
1
Educational Status
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Venous Thromboembolism
×
Enoxaparin
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts